Spontaneous evolution patterns of focal congenital hepatic hemangiomas: a case series of 25 patients.


Journal

Pediatric radiology
ISSN: 1432-1998
Titre abrégé: Pediatr Radiol
Pays: Germany
ID NLM: 0365332

Informations de publication

Date de publication:
05 2022
Historique:
received: 23 07 2021
accepted: 22 12 2021
revised: 10 11 2021
pubmed: 2 3 2022
medline: 18 5 2022
entrez: 1 3 2022
Statut: ppublish

Résumé

Hepatic hemangiomas are the most common benign liver tumors of infancy. They are termed congenital if fully developed at birth or infantile if they appear in the first weeks of life. Previous studies suggested that most focal hepatic hemangiomas are congenital in nature, exhibit no postnatal growth and have an evolution that parallels their cutaneous counterparts. They are subdivided by pattern of involution, whether rapidly involuting (RICH), partially involuting (PICH) or non-involuting (NICH) congenital hemangiomas. In our experience, some focal hepatic hemangiomas show postnatal growth, behaving like infantile forms. To analyze the spontaneous evolution of focal congenital hepatic hemangiomas with quantification of tumor volume changes over time and to identify initial postnatal ultrasound (US) imaging biomarkers predictive of their evolution pattern. A retrospective review of clinical, imaging and pathology data of children diagnosed with focal congenital hepatic hemangioma (prenatal diagnosis or age at diagnosis <7 days and/or glucose transporter protein 1 [GLUT1]-negative tumor) diagnosed between 2000 and 2018 was performed with analysis of tumor volume changes over time. Exclusion criteria were treatment inducing a tumor volume change (hepatic artery embolization, propranolol, or corticosteroids), imaging follow-up less than 1 month or fewer than two US examinations. Volumetric analysis was based on US and cross-sectional imaging. Lesion volumes were estimated using the standard ellipsoid formula. A 35% margin of error was assumed for tumor volume variation to account for variability in measurements. Imaging studies, including US, computed tomography, and magnetic resonance imaging, were reviewed and initial postnatal US features were correlated with evolution pattern. Twenty-five patients with focal congenital hepatic hemangiomas were included. The median follow-up time was 46.5 months (range: 4-144 months). Eight (32%) lesions showed postnatal growth before involuting, without signs of intralesional hemorrhage, as do cutaneous infantile hemangiomas. The other 17 (68%) lesions exhibited a strict decrease in volume with age, of which 15 underwent complete involution (8 before age 18 months and 7 after age 18 months) and 2 underwent partial involution. The different evolution patterns of focal congenital hepatic hemangiomas showed overlapping imaging features and we found no initial US feature to be significantly associated with postnatal growth. However, large vascular spaces with marked vascularity at US were noted in three of the eight rapidly involuting lesions. Focal congenital hepatic hemangiomas are not the equivalent of cutaneous RICH, as some may increase in size and tumor regression may be rapid or slow. The different evolution patterns of focal congenital hepatic hemangiomas show overlapping US features.

Sections du résumé

BACKGROUND
Hepatic hemangiomas are the most common benign liver tumors of infancy. They are termed congenital if fully developed at birth or infantile if they appear in the first weeks of life. Previous studies suggested that most focal hepatic hemangiomas are congenital in nature, exhibit no postnatal growth and have an evolution that parallels their cutaneous counterparts. They are subdivided by pattern of involution, whether rapidly involuting (RICH), partially involuting (PICH) or non-involuting (NICH) congenital hemangiomas. In our experience, some focal hepatic hemangiomas show postnatal growth, behaving like infantile forms.
OBJECTIVES
To analyze the spontaneous evolution of focal congenital hepatic hemangiomas with quantification of tumor volume changes over time and to identify initial postnatal ultrasound (US) imaging biomarkers predictive of their evolution pattern.
MATERIALS AND METHODS
A retrospective review of clinical, imaging and pathology data of children diagnosed with focal congenital hepatic hemangioma (prenatal diagnosis or age at diagnosis <7 days and/or glucose transporter protein 1 [GLUT1]-negative tumor) diagnosed between 2000 and 2018 was performed with analysis of tumor volume changes over time. Exclusion criteria were treatment inducing a tumor volume change (hepatic artery embolization, propranolol, or corticosteroids), imaging follow-up less than 1 month or fewer than two US examinations. Volumetric analysis was based on US and cross-sectional imaging. Lesion volumes were estimated using the standard ellipsoid formula. A 35% margin of error was assumed for tumor volume variation to account for variability in measurements. Imaging studies, including US, computed tomography, and magnetic resonance imaging, were reviewed and initial postnatal US features were correlated with evolution pattern.
RESULTS
Twenty-five patients with focal congenital hepatic hemangiomas were included. The median follow-up time was 46.5 months (range: 4-144 months). Eight (32%) lesions showed postnatal growth before involuting, without signs of intralesional hemorrhage, as do cutaneous infantile hemangiomas. The other 17 (68%) lesions exhibited a strict decrease in volume with age, of which 15 underwent complete involution (8 before age 18 months and 7 after age 18 months) and 2 underwent partial involution. The different evolution patterns of focal congenital hepatic hemangiomas showed overlapping imaging features and we found no initial US feature to be significantly associated with postnatal growth. However, large vascular spaces with marked vascularity at US were noted in three of the eight rapidly involuting lesions.
CONCLUSION
Focal congenital hepatic hemangiomas are not the equivalent of cutaneous RICH, as some may increase in size and tumor regression may be rapid or slow. The different evolution patterns of focal congenital hepatic hemangiomas show overlapping US features.

Identifiants

pubmed: 35229180
doi: 10.1007/s00247-021-05277-4
pii: 10.1007/s00247-021-05277-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1048-1060

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Wassef M, Blei F, Adams D et al (2015) Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics 136:e203–e214
doi: 10.1542/peds.2014-3673
Merrow AC, Gupta A, Patel MN, Adams DM (2016) 2014 revised classification of vascular lesions from the International Society for the Study of vascular anomalies: radiologic-pathologic update. Radiographics 36:1494–1516
doi: 10.1148/rg.2016150197
Mulliken JB, Enjolras O (2004) Congenital hemangiomas and infantile hemangioma: missing links. J Am Acad Dermatol 50:875–882
doi: 10.1016/j.jaad.2003.10.670
Gorincour G, Kokta V, Rypens F et al (2005) Imaging characteristics of two subtypes of congenital hemangiomas: rapidly involuting congenital hemangiomas and non-involuting congenital hemangiomas. Pediatr Radiol 35:1178–1185
doi: 10.1007/s00247-005-1557-9
George A, Mani V, Noufal A (2014) Update on the classification of hemangioma. J Oral Maxillofac Pathol 18:S117–S120
doi: 10.4103/0973-029X.141321
Nasseri E, Piram M, McCuaig CC et al (2014) Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature. J Am Acad Dermatol 70:75–79
doi: 10.1016/j.jaad.2013.09.018
El Zein S, Boccara O, Soupre V et al (2020) The histopathology of congenital haemangioma and its clinical correlations: a long-term follow-up study of 55 cases. Histopathology 77:275–283
doi: 10.1111/his.14114
Kulungowski AM, Alomari AI, Chawla A et al (2012) Lessons from a liver hemangioma registry: subtype classification. J Pediatr Surg 47:165–170
doi: 10.1016/j.jpedsurg.2011.10.037
Christison-Lagay ER, Burrows PE, Alomari A et al (2007) Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 42:62–68
doi: 10.1016/j.jpedsurg.2006.09.041
Roebuck D, Sebire N, Lehmann E, Barnacle A (2012) Rapidly involuting congenital haemangioma (RICH) of the liver. Pediatr Radiol 42:308–314
doi: 10.1007/s00247-011-2268-z
Mo JQ, Dimashkieh HH, Bove KE (2004) GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol 35:200–209
doi: 10.1016/j.humpath.2003.09.017
Hernández F, Navarro M, Encinas JL et al (2005) The role of GLUT1 immunostaining in the diagnosis and classification of liver vascular tumors in children. J Pediatr Surg 40:801–804
doi: 10.1016/j.jpedsurg.2005.01.046
Franchi-Abella S, Gorincour G, Avni F et al (2012) Hepatic haemangioma-prenatal imaging findings, complications and perinatal outcome in a case series. Pediatr Radiol 42:298–307
doi: 10.1007/s00247-011-2214-0
Venables WN, Ripley BD (2002) Modern applied statistics with S, 4th edn. Springer
doi: 10.1007/978-0-387-21706-2
Ritz C, Baty F, Streibig JC, Gerhard D (2016) Dose-response analysis using R. PLoS One 10:1–13
Enjolras O, Mulliken JB, Boon LM et al (2001) Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 107:1647–1654
doi: 10.1097/00006534-200106000-00002
Cossio ML, Dubois J, McCuaig CC et al (2019) Non-involuting congenital hemangiomas (NICH) with postnatal atypical growth: a case series. Pediatr Dermatol 36:466–470
pubmed: 31033005
Triana P, Rodríguez-Laguna L, Giacaman A et al (2020) Congenital hepatic hemangiomas: clinical, histologic, and genetic correlation. J Pediatr Surg 55:2170–2176
doi: 10.1016/j.jpedsurg.2020.02.008
Gembruch U, Baschat AA, Gloeckner-Hoffmann K et al (2002) Prenatal diagnosis and management of fetuses with liver hemangiomata. Ultrasound Obstet Gynecol 19:454–460
doi: 10.1046/j.1469-0705.2002.00689.x
Li K, Wang Z, Liu Y et al (2016) Fine clinical differences between patients with multifocal and diffuse hepatic hemangiomas. J Pediatr Surg 51:2086–2090
doi: 10.1016/j.jpedsurg.2016.09.045
Jiao-Ling L, Xiu-Ping G, Kun-Shan C et al (2018) Huge fetal hepatic hemangioma: prenatal diagnosis on ultrasound and prognosis. BMC Pregnancy Childbirth 18:2
doi: 10.1186/s12884-017-1635-7
Choi YJ, Baek JH, Hong MJ, Lee JH (2015) Inter-observer variation in ultrasound measurement of the volume and diameter of thyroid nodules. Korean J Radiol 16:560–565
doi: 10.3348/kjr.2015.16.3.560

Auteurs

Caroline Rutten (C)

Department of Pediatric Radiology, Bicêtre Hospital, 78 Rue du Général Leclerc, 94270, Le Kremlin-Bicêtre, France.

Delphine Ladarre (D)

Department of Pediatric Hepatology and Liver Transplantation, Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France.
Reference Centre for Vascular Diseases of the Liver, FSMR FILFOIE, ERN RARE LIVER, Bicêtre Hospital, AP-HP, FHU Hépatinov, Paris-Saclay University, Le Kremlin-Bicêtre, France.

Oanez Ackermann (O)

Department of Pediatric Hepatology and Liver Transplantation, Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France.
Reference Centre for Vascular Diseases of the Liver, FSMR FILFOIE, ERN RARE LIVER, Bicêtre Hospital, AP-HP, FHU Hépatinov, Paris-Saclay University, Le Kremlin-Bicêtre, France.

Emmanuel Gonzales (E)

Department of Pediatric Hepatology and Liver Transplantation, Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France.
Reference Centre for Vascular Diseases of the Liver, FSMR FILFOIE, ERN RARE LIVER, Bicêtre Hospital, AP-HP, FHU Hépatinov, Paris-Saclay University, Le Kremlin-Bicêtre, France.
INSERM UMRS 1193, Paris-Saclay University, FHU Hépatinov, Orsay, France.

Catherine Guettier (C)

Reference Centre for Vascular Diseases of the Liver, FSMR FILFOIE, ERN RARE LIVER, Bicêtre Hospital, AP-HP, FHU Hépatinov, Paris-Saclay University, Le Kremlin-Bicêtre, France.
INSERM UMRS 1193, Paris-Saclay University, FHU Hépatinov, Orsay, France.
Department of Pathology, Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France.

Stéphanie Franchi-Abella (S)

Department of Pediatric Radiology, Bicêtre Hospital, 78 Rue du Général Leclerc, 94270, Le Kremlin-Bicêtre, France. stephanie.franchi@aphp.fr.
Reference Centre for Vascular Diseases of the Liver, FSMR FILFOIE, ERN RARE LIVER, Bicêtre Hospital, AP-HP, FHU Hépatinov, Paris-Saclay University, Le Kremlin-Bicêtre, France. stephanie.franchi@aphp.fr.
DMU Smart Imaging, BIOMAPS UMR 9011 CNRS - INSERM - CEA, Le Kremlin-Bicêtre, France. stephanie.franchi@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH